Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Research (Washington, D.C.)
|
June 15, 2026
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma
Yan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Signal Transduction and Targeted Therapy
|
March 14, 2026
Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumors
Yan-Ruide Li, Miao Li, Yuning Chen, et al.
Circulation Research
|
April 30, 2025
Habitual Exercise Modulates Neuroimmune Interaction to Mitigate Aortic Stiffness
Jae Min Cho, Khoa Vu, Seul-Ki Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 14, 2025
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety
Yan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Nature Communications
|
June 11, 2021
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
Yu-Chen Wang, Xi Wang, Jiaji Yu, et al.
Iscience
|
April 20, 2026
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Elliot Kang, James Elsten-Brown, Yu-Chen Wang, et al.
Iscience
|
October 9, 2023
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
Yan-Ruide Li, Christopher J Ochoa, Yichen Zhu, et al.
Nature Nanotechnology
|
September 23, 2024
Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies
Enbo Zhu, Jiaji Yu, Yan-Ruide Li, et al.
Nature Communications
|
November 8, 2023
Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering
Derek Lee, Zachary Spencer Dunn, Wenbin Guo, et al.
Nature Communications
|
February 1, 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Siyue Niu, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Research (Washington, D.C.)
|
June 15, 2026
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma
Yan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Signal Transduction and Targeted Therapy
|
March 14, 2026
Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumors
Yan-Ruide Li, Miao Li, Yuning Chen, et al.
Circulation Research
|
April 30, 2025
Habitual Exercise Modulates Neuroimmune Interaction to Mitigate Aortic Stiffness
Jae Min Cho, Khoa Vu, Seul-Ki Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 14, 2025
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety
Yan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Nature Communications
|
June 11, 2021
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
Yu-Chen Wang, Xi Wang, Jiaji Yu, et al.
Iscience
|
April 20, 2026
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Elliot Kang, James Elsten-Brown, Yu-Chen Wang, et al.
Iscience
|
October 9, 2023
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
Yan-Ruide Li, Christopher J Ochoa, Yichen Zhu, et al.
Nature Nanotechnology
|
September 23, 2024
Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies
Enbo Zhu, Jiaji Yu, Yan-Ruide Li, et al.
Nature Communications
|
November 8, 2023
Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering
Derek Lee, Zachary Spencer Dunn, Wenbin Guo, et al.
Nature Communications
|
February 1, 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Siyue Niu, et al.
Page
of 10